Expression of HLA class II genes in alveolar macrophages of patients with sarcoidosis

J. R. Spurzem, C. Saltini, M. Kirby, K. Konishi, Ronald Crystal

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Sarcoidosis is characterized by the accumulation of activated helper/inducer T-cells and macrophages at sites of disease. The accumulation of these T-cells may be related to the ability of sarcoid alveolar macrophages to present antigen and stimulate lymphocyte proliferation in an exaggerated fashion. In the context that HLA Class II gene (HLA-DR, DQ, and DP) expression is essential to the interaction of lymphocytes with antigen-presenting cells such as macrophages, we have evaluated the hypothesis that the expression of Class II genes may be up-regulated in sarcoid alveolar macrophages. Northern blot and dot blot analysis with 32P-labeled cDNA probes for HLA-DR, DQ, and DP genes revealed that both normal and sarcoid alveolar macrophages contain Class II mRNA transcripts, but that the levels in sarcoid and normal alveolar macrophages are similar (p > 0.3, all comparisons). Furthermore, evaluation of surface expression of Class II molecules with monoclonal antibodies and flow cytometry analysis demonstrated that alveolar macrophages of both patients with sarcoidosis and normal subjects express all three Class II molecules, DR, DQ, and DP, but there were no significant differences between sarcoid patients and normal subjects in the proportions of macrophages expressing these surface molecules. However, there was a significantly higher surface density of Class II molecules on sarcoid alveolar macrophages (p < 0.05, all comparisons sarcoid to normal). Thus, enhanced surface expression of Class II molecules is observed on sarcoid alveolar macrophages, consistent with the concept that the expression of Class II molecules may play an important role in the ability of sarcoid alveolar macrophages to present antigen and stimulate lymphocytes, explaining in part the accumulation of activated helper T-cells in sarcoidosis.

Original languageEnglish
Pages (from-to)89-94
Number of pages6
JournalAmerican Review of Respiratory Disease
Volume140
Issue number1
DOIs
Publication statusPublished - 1 Jan 1989
Externally publishedYes

Fingerprint

MHC Class II Genes
Alveolar Macrophages
Sarcoidosis
HLA-DP Antigens
HLA-DQ Antigens
Macrophages
HLA-DR Antigens
Lymphocytes
Helper-Inducer T-Lymphocytes
Antigens
Antigen-Presenting Cells
Northern Blotting
Flow Cytometry
Complementary DNA
Monoclonal Antibodies
T-Lymphocytes
Messenger RNA

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Expression of HLA class II genes in alveolar macrophages of patients with sarcoidosis. / Spurzem, J. R.; Saltini, C.; Kirby, M.; Konishi, K.; Crystal, Ronald.

In: American Review of Respiratory Disease, Vol. 140, No. 1, 01.01.1989, p. 89-94.

Research output: Contribution to journalArticle

Spurzem, J. R. ; Saltini, C. ; Kirby, M. ; Konishi, K. ; Crystal, Ronald. / Expression of HLA class II genes in alveolar macrophages of patients with sarcoidosis. In: American Review of Respiratory Disease. 1989 ; Vol. 140, No. 1. pp. 89-94.
@article{a364eb5cd8e146568f4b4e22bbfbe68a,
title = "Expression of HLA class II genes in alveolar macrophages of patients with sarcoidosis",
abstract = "Sarcoidosis is characterized by the accumulation of activated helper/inducer T-cells and macrophages at sites of disease. The accumulation of these T-cells may be related to the ability of sarcoid alveolar macrophages to present antigen and stimulate lymphocyte proliferation in an exaggerated fashion. In the context that HLA Class II gene (HLA-DR, DQ, and DP) expression is essential to the interaction of lymphocytes with antigen-presenting cells such as macrophages, we have evaluated the hypothesis that the expression of Class II genes may be up-regulated in sarcoid alveolar macrophages. Northern blot and dot blot analysis with 32P-labeled cDNA probes for HLA-DR, DQ, and DP genes revealed that both normal and sarcoid alveolar macrophages contain Class II mRNA transcripts, but that the levels in sarcoid and normal alveolar macrophages are similar (p > 0.3, all comparisons). Furthermore, evaluation of surface expression of Class II molecules with monoclonal antibodies and flow cytometry analysis demonstrated that alveolar macrophages of both patients with sarcoidosis and normal subjects express all three Class II molecules, DR, DQ, and DP, but there were no significant differences between sarcoid patients and normal subjects in the proportions of macrophages expressing these surface molecules. However, there was a significantly higher surface density of Class II molecules on sarcoid alveolar macrophages (p < 0.05, all comparisons sarcoid to normal). Thus, enhanced surface expression of Class II molecules is observed on sarcoid alveolar macrophages, consistent with the concept that the expression of Class II molecules may play an important role in the ability of sarcoid alveolar macrophages to present antigen and stimulate lymphocytes, explaining in part the accumulation of activated helper T-cells in sarcoidosis.",
author = "Spurzem, {J. R.} and C. Saltini and M. Kirby and K. Konishi and Ronald Crystal",
year = "1989",
month = "1",
day = "1",
doi = "10.1164/ajrccm/140.1.89",
language = "English",
volume = "140",
pages = "89--94",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "1",

}

TY - JOUR

T1 - Expression of HLA class II genes in alveolar macrophages of patients with sarcoidosis

AU - Spurzem, J. R.

AU - Saltini, C.

AU - Kirby, M.

AU - Konishi, K.

AU - Crystal, Ronald

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Sarcoidosis is characterized by the accumulation of activated helper/inducer T-cells and macrophages at sites of disease. The accumulation of these T-cells may be related to the ability of sarcoid alveolar macrophages to present antigen and stimulate lymphocyte proliferation in an exaggerated fashion. In the context that HLA Class II gene (HLA-DR, DQ, and DP) expression is essential to the interaction of lymphocytes with antigen-presenting cells such as macrophages, we have evaluated the hypothesis that the expression of Class II genes may be up-regulated in sarcoid alveolar macrophages. Northern blot and dot blot analysis with 32P-labeled cDNA probes for HLA-DR, DQ, and DP genes revealed that both normal and sarcoid alveolar macrophages contain Class II mRNA transcripts, but that the levels in sarcoid and normal alveolar macrophages are similar (p > 0.3, all comparisons). Furthermore, evaluation of surface expression of Class II molecules with monoclonal antibodies and flow cytometry analysis demonstrated that alveolar macrophages of both patients with sarcoidosis and normal subjects express all three Class II molecules, DR, DQ, and DP, but there were no significant differences between sarcoid patients and normal subjects in the proportions of macrophages expressing these surface molecules. However, there was a significantly higher surface density of Class II molecules on sarcoid alveolar macrophages (p < 0.05, all comparisons sarcoid to normal). Thus, enhanced surface expression of Class II molecules is observed on sarcoid alveolar macrophages, consistent with the concept that the expression of Class II molecules may play an important role in the ability of sarcoid alveolar macrophages to present antigen and stimulate lymphocytes, explaining in part the accumulation of activated helper T-cells in sarcoidosis.

AB - Sarcoidosis is characterized by the accumulation of activated helper/inducer T-cells and macrophages at sites of disease. The accumulation of these T-cells may be related to the ability of sarcoid alveolar macrophages to present antigen and stimulate lymphocyte proliferation in an exaggerated fashion. In the context that HLA Class II gene (HLA-DR, DQ, and DP) expression is essential to the interaction of lymphocytes with antigen-presenting cells such as macrophages, we have evaluated the hypothesis that the expression of Class II genes may be up-regulated in sarcoid alveolar macrophages. Northern blot and dot blot analysis with 32P-labeled cDNA probes for HLA-DR, DQ, and DP genes revealed that both normal and sarcoid alveolar macrophages contain Class II mRNA transcripts, but that the levels in sarcoid and normal alveolar macrophages are similar (p > 0.3, all comparisons). Furthermore, evaluation of surface expression of Class II molecules with monoclonal antibodies and flow cytometry analysis demonstrated that alveolar macrophages of both patients with sarcoidosis and normal subjects express all three Class II molecules, DR, DQ, and DP, but there were no significant differences between sarcoid patients and normal subjects in the proportions of macrophages expressing these surface molecules. However, there was a significantly higher surface density of Class II molecules on sarcoid alveolar macrophages (p < 0.05, all comparisons sarcoid to normal). Thus, enhanced surface expression of Class II molecules is observed on sarcoid alveolar macrophages, consistent with the concept that the expression of Class II molecules may play an important role in the ability of sarcoid alveolar macrophages to present antigen and stimulate lymphocytes, explaining in part the accumulation of activated helper T-cells in sarcoidosis.

UR - http://www.scopus.com/inward/record.url?scp=0024399551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024399551&partnerID=8YFLogxK

U2 - 10.1164/ajrccm/140.1.89

DO - 10.1164/ajrccm/140.1.89

M3 - Article

C2 - 2526608

AN - SCOPUS:0024399551

VL - 140

SP - 89

EP - 94

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 1

ER -